Association of Northern California Oncologists (ANCO) Clinical Cancer Update 2025

Association of Northern California Oncologists (ANCO) Clinical Cancer Update 2025 is organized by Association of Northern California Oncologists (ANCO) and will be held from Jan 31 - Feb 02, 2025 at Everline Resort & Spa Lake Tahoe - Destination by Hyatt, Olympic Valley, California, United States of America.

Description:
This three-day meeting is designed to provide healthcare professionals with a deep dive into the latest advances in the treatment, early detection, and prevention of a wide range of cancers.  The sessions will focus on Breast Cancer, Hematologic Malignancies, Melanoma & Developmental Therapeutics, Gastrointestinal and Genitourinary Cancers, Head & Neck in conjunction with the Central Nervous System, and finally Lung Cancer.

Not only will you take away some valuable information, but you will have the opportunity to connect with like-minded peers and industry supporters.

Learning Objectives:

• Recognize and apply the latest advancements in clinical management for patients with breast, colorectal, genitourinary, and lung cancers, as well as leukemia, lymphoma, melanoma, and osteosarcoma.
• Evaluate the most up-to-date chemotherapy and radiation therapy protocols for patients with breast, colorectal, genitourinary, and lung cancers; leukemia, lymphoma, melanoma, and osteosarcoma, and integrate these treatments into clinical practice.
• Identify appropriate indications for surgical intervention in breast, colorectal, genitourinary, and lung cancers, as well as melanoma and osteosarcoma, and incorporate surgical decision-making into multidisciplinary care plans.
• Gain a comprehensive understanding of recent discoveries in translational science, focusing on their relevance to breast, colorectal, genitourinary, and lung cancers; leukemia, lymphoma, melanoma, and osteosarcoma, and their potential clinical implications.
• Identify and integrate emerging therapies for patients with breast, colorectal, genitourinary, and lung cancers, as well as leukemia, lymphoma, melanoma, and osteosarcoma, into individualized treatment approaches.